NAS10026,990+1.35%S&P7,377+0.31%GOLD$4,075−0.94%BTC$75,677−0.09%VIX25.64−9.01%latest tape · as of 20:08 UTC
The Screen · Financials · Capital Markets
Goldman Sachs
GS · a US exchange · USD · Market cap $270.1B · 47,000 employees
The Goldman Sachs Group, Inc., a financial institution, provides a range of financial services for corporations, financial institutions, governments, and individuals in the Americas, Europe, the Middle East, Africa, and Asia.
FAIL · Does not pass the screen
865.82 USD
Price as of 6 Nov 2026Daily close, not a live quote
Screened 2026-11-06 · the tape above runs as of 20:08 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
Key facts today
Price865.82 USD at the 6 Nov 2026 close
Our value readUndervalued vs our fair value, as of 6 Nov 2026
Positioning political buying, disclosed 2026-10-20
Options put/call open interest 0.97, read 2026-11-02
Ethical does not pass the values gate
Price865.82 USD
Fair value1,060.69
Ethical score10.0/100
Value readUndervaluedas of 6 Nov 2026
Our investment reviews on this name
2026-11-03Read Accumulation894.55-3.2% to today Markdown gives way to Accumulation
2026-10-10Read Markdown935.45-7.4% to today ✓Distribution gives way to Markdown with volume flow in agreement
2026-10-02Read Distribution935.45-7.4% to today ✓Accumulation gives way to Distribution after a 7% slide in 5 weeks
2026-08-31Read Accumulation1,001.95-13.6% to today Markup gives way to Accumulation while volume is distributing
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
Goldman Sachs holds its Markup at $865.82. Consolidating, no directional conviction, held for 56 days.
As held on the ledger · 2026-11-06
Phase
Markup
Quantitative state
Consolidating, no directional conviction, held for 56 days
Price at the screen
$865.82
Valuation
13.34 trailing · 12.52 forward price to earnings
Values screen
FAIL· score 10.0
Beta
1.28
The Workings
Five Screens, Shown in Full
Does not pass. Business activity screen
Test
Figure
Limit
What it means
Status
Business activity
Excluded
Core business clean
Business activity: Financials sector
Fail
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical Read
Why It Falls Short, in Plain English
Goldman Sachs does not clear the screen at the business-activity stage. It operates in conventional financial services, which the screen treats as interest-based, so the financial ratios are not the deciding factor here.
Read as at 2026-11-07. It updates when the underlying figures move, and past reads are kept below.
Follow this verdict
Get an email when GS's ethical verdict changes
Today GS does not pass the screen. If new figures move it to a pass, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.
Free, no account needed. Every email has a link to stop.
The quantitative screen above is arithmetic. Separately, community boycott lists cite this company: Cited by BDS movement for investment banking services and holdings in companies operating in or supporting Israeli settlements. The desk records that flag here without folding it into the verdict: the screen measures the balance sheet, the overlay informs the conscience, and they are different judgements that belong to different owners. The second one is yours.
What the Numbers Say It Is Worth
The Fair Value Range
Our analysis reads Undervalued vs our fair value, as of 6 Nov 2026: it trades at roughly an 18% discount to our $1,060.69 fair value, moderate competitive moat, 23.30% revenue growth.
Fair value range in USD, drawn from the 2026-11-06 screen. The gold marker is the market price at the same screen. A 18.4% discount to the base estimate.
Where our models see it going: fair-value estimate $1,060.69, with a range of $833.53 to $1,389.22, dated to the 2026-11-06 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain Words
Why it stands out
A 23%-growth business trading at just 12.5x forward earnings, with a moderate competitive moat. That is an 18% discount to our $1,060.69 fair value: the market is pricing it cautiously while the fundamentals argue otherwise. 21 analysts rate it Buy with a $1,010.00 average target, about 17% above the screened price.
Another profit measure, before interest, tax and non-cash costs: EBITDA.
The risks · The things to watch: it carries a real debt load, which raises the stakes if revenue slips.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to Trade
GS trades on a US exchange. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The framework has shifted from markdown to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 0.4% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 6% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 66%. Our forward projection puts the odds of a 10% gain over the next month near 32%. The street (21 analysts) rates it buy, with a mean price target of $1031. Insiders have been net sellers over the past quarter.
2026-10-27Markdown$891.28+0.0%Entry 12
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 6% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 66%. Our forward projection puts the odds of a 10% gain over the next month near 32%. The street (21 analysts) rates it buy, with a mean price target of $1031. Insiders have been net sellers over the past quarter.
2026-10-20Markdown$891.28-0.5%Entry 11
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.5% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 5% above its long-term trend line with momentum reading bearish. Over the past year the shares are up 66%. Our forward projection puts the odds of a 10% gain over the next month near 32%. The street (21 analysts) rates it hold, with a mean price target of $1038. Insiders have been net sellers over the past quarter.
2026-10-13Markdown$895.32+0.0%Entry 10
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 18% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 66%. Our forward projection puts the odds of a 10% gain over the next month near 32%. The street (21 analysts) rates it hold, with a mean price target of $1069. Insiders have been net sellers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-12Markdown$895.32-4.3%Entry 9
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 4.3% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 18% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 66%. Our forward projection puts the odds of a 10% gain over the next month near 32%. The street (21 analysts) rates it hold, with a mean price target of $1078. Insiders have been net sellers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-11Markdown$935.45+0.0%Entry 8
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 18% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 66%. Our forward projection puts the odds of a 10% gain over the next month near 32%. The street (21 analysts) rates it hold, with a mean price target of $1078. Insiders have been net sellers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-10Markdown · changed$935.45+0.0%Entry 7
The framework has shifted from distribution to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 18% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 66%. Our forward projection puts the odds of a 10% gain over the next month near 32%. The street (21 analysts) rates it hold, with a mean price target of $1078. Insiders have been net sellers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.
The framework has shifted from accumulation to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 6.6% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 18% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 66%. Our forward projection puts the odds of a 10% gain over the next month near 32%. The street (20 analysts) rates it hold, with a mean price target of $1127. Insiders have been net sellers over the past quarter.
The framework has shifted from markup to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 5.6% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 18% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 66%. Our forward projection puts the odds of a 10% gain over the next month near 32%. The street (20 analysts) rates it hold, with a mean price target of $1142. Insiders have been net sellers over the past quarter.
2026-07-31Markup$1,061.23+2.2%Entry 4
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 2.2% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 18% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 66%. Our forward projection puts the odds of a 10% gain over the next month near 32%. The street (20 analysts) rates it hold, with a mean price target of $948. Insiders have been net sellers over the past quarter.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
